Economic and clinical burden associated with respiratory viral infections after allogeneic hematopoietic cell transplant in the United States.
Michael G IsonFrancisco M MartyNelson ChaoSeung Hyun MoonZhiji ZhangAastha ChandakPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2022)
Allo-HCT patients with RVIs had significantly worse clinical outcomes and increased health resource utilization and reimbursements during the year following allo-HCT, with or without GVHD.
Keyphrases
- bone marrow
- stem cell transplantation
- cell cycle arrest
- healthcare
- public health
- single cell
- sars cov
- mental health
- allogeneic hematopoietic stem cell transplantation
- health information
- risk factors
- hematopoietic stem cell
- health promotion
- low dose
- acute myeloid leukemia
- social media
- climate change
- pi k akt
- human health